SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
ATLANTA, Oct. 10, 2017 -- Matrix Surgical USA introduced patented (#US0D0794794) innovations designed to address two of the etiologies that most frequently cause cranial implant exposure at the CNS 2017 Annual Meeting. While computer designed and manufactured implants allow precise anatomic reconstruction of skull defects, they can be plagued by complications requiring implant removal.
“Cranial implant exposure is not uncommon and results in significant, avoidable patient morbidity and expense,” said Dr. Michael J. Yaremchuk, Chief of Craniofacial Surgery, Massachusetts General Hospital. Dr. Yaremchuk designed the cranioplasty innovations which are exclusively licensed to Matrix Surgical.
Affixing Cranial Implants
The plates and screws that typically affix cranial implants to the adjacent intact cranium almost inevitably have a profile above the surface of the implant/skull interface. Matrix Surgical’s new, patented lag screw design not only eliminates the problem of prominent fixation hardware, it also streamlines and simplifies the fixation process.
During the computer design process, the surgeon has the ability to select where the oblique holes are placed in the implant that allows fixation screws to remain within the surface contour of the implant.
Integrating Subcranial Drains
Decreases in brain volume following trauma or neurosurgery can lead to the creation of a space between the surface of the brain and the cranial implant. Fluid inevitably collects in this space and is susceptible to contamination and infection.
With Matrix Surgical’s patented design, a drain hole is strategically positioned in the implant to allow passage of a removable drain between the cranial cavity and the inner surface of the skull. The drain port’s dimensions can be customized to fit the surgeon’s preferred drain.
About Matrix Surgical USA
Matrix Surgical USA is a privately owned American company dedicated to the design, production, marketing and distribution of sterile, biocompatible craniofacial implants. Matrix Surgical USA offers its products to healthcare providers in the United States and in more than 60 countries around the world. Learn more at www.MatrixSurgicalUSA.com.
Media Contact: Lynn Hood, [email protected], 678-974-2623
